CryoLife Announces Sale of PerClot to Baxter

ATLANTA, July 29, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has completed the sale of its PerClot product line to a subsidiary of Baxter International, Inc. ("Baxter") (NYSE: BAX ),...]]>Read More...

To receive a free e-mail notification whenever CryoLife makes a similar move, sign up!

Other recent filings from the company include the following:

Other preliminary proxy statements - Sept. 24, 2021
CryoLife: N E W S R E L E A S E FOR IMMEDIATE RELEASE Contacts: - Sept. 22, 2021
SVP of CryoLife just disposed of 663 shares - Sept. 1, 2021
CryoLife director just cashed-in 3,645 options - Aug. 31, 2021

Auto Refresh

Feedback